Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-16,000
Closed -$7.23K 2796
2025
Q2
$7.23K Hold
16,000
﹤0.01% 2587
2025
Q1
$6.51K Hold
16,000
﹤0.01% 2538
2024
Q4
$10.6K Hold
16,000
﹤0.01% 2503
2024
Q3
$13.6K Hold
16,000
﹤0.01% 2480
2024
Q2
$10.7K Buy
+16,000
New +$13.3K ﹤0.01% 2633
2021
Q2
Sell
-30,600
Closed -$185K 2819
2021
Q1
$185K Buy
+30,600
New +$235K ﹤0.01% 2516

Other funds holding VXRT

Truist Financial's VXRT Position: Q3 2025 in Review

Truist Financial sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 16,000 shares — an estimated $7.23K sold.

Truist Financial first reported a position in VXRT in Q1 2021 and held it in 6 quarters. The position peaked at $185K in Q1 2021. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Truist Financial reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Truist Financial sold 16,000 Vaxart shares in Q3 2025, an estimated $7.23K.
  • Truist Financial first reported a position in Vaxart in Q1 2021 and held it in 6 quarters.
  • Truist Financial's Vaxart position peaked at $185K in Q1 2021.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Truist Financial's 13F filing for Q3 2025, filed 3 Nov 2025.